Chemical activators of Serum Amyloid A2 (SAA2) engage various cellular pathways to enhance its activation. Anisomycin, a potent activator, works through the stress-activated protein kinase (SAPK) pathway. When anisomycin is present, SAPK becomes active, which results in the phosphorylation of transcription factors that play a role in SAA2 activation. Similarly, Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which then phosphorylates downstream targets that contribute to SAA2 activation. Ionomycin, by increasing intracellular calcium levels, activates calcium-dependent kinases, which then phosphorylate and activate proteins in the signaling pathways that include SAA2. Forskolin, by raising cAMP levels, activates protein kinase A (PKA), which can phosphorylate proteins within the SAA2 signaling cascade, leading to its activation.
Furthermore, Bryostatin 1, by binding to PKC, modulates its activity, which can result in the activation of proteins that are part of the SAA2 signaling pathways. Okadaic Acid and Calyculin A, both phosphatase inhibitors, maintain proteins in a phosphorylated state, which is a prerequisite for the activation of many signaling proteins, including those that activate SAA2. Endothall also inhibits protein phosphatases, thereby promoting the phosphorylation and subsequent activation of proteins that can activate SAA2. Thapsigargin, by disrupting calcium homeostasis, activates calcium signaling pathways that lead to SAA2 activation. Mevalonolactone, through its role in isoprenoid biosynthesis, can result in the prenylation and subsequent activation of proteins that are crucial for SAA2 activation. Bisindolylmaleimide I, a PKC inhibitor, can indirectly cause the compensatory activation of alternative kinases that can activate SAA2. Lastly, Cantharidin inhibits protein phosphatases, which leads to the phosphorylation and activation of proteins within the SAA2 activation pathways. Each of these chemicals, through their specific action on different cellular pathways and signaling molecules, contribute to the activation of SAA2.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates the stress-activated protein kinase (SAPK) pathway, which can phosphorylate various downstream targets including transcription factors that can enhance the activation of SAA2. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which in turn can phosphorylate and activate downstream proteins that may lead to the activation of SAA2. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium concentration, which activates calcium-dependent kinases that can phosphorylate and activate proteins within signaling pathways that include SAA2. | ||||||
Bryostatin 1 | 83314-01-6 | sc-201407 | 10 µg | $245.00 | 9 | |
Bryostatin 1 binds to and modulates PKC, which can lead to the activation of downstream proteins involved in the signaling pathways that activate SAA2. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid inhibits protein phosphatases PP1 and PP2A, maintaining phosphorylation states of proteins within signaling pathways, which can lead to the activation of SAA2. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A, like Okadaic Acid, inhibits protein phosphatases leading to sustained phosphorylation and activation of proteins in signaling pathways that include SAA2. | ||||||
Endothall | 145-73-3 | sc-201325 sc-201325A | 20 mg 100 mg | $49.00 $203.00 | 1 | |
Endothall inhibits protein phosphatases, promoting a phosphorylated state of proteins in pathways that lead to the activation of SAA2. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis, which can lead to the activation of calcium-signaling pathways and protein kinases that activate SAA2. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I inhibits PKC, which can cause compensatory activation of alternative kinases within pathways that lead to the activation of SAA2. | ||||||
Cantharidin | 56-25-7 | sc-201321 sc-201321A | 25 mg 100 mg | $89.00 $279.00 | 6 | |
Cantharidin inhibits protein phosphatases, leading to a sustained phosphorylation and activation of proteins in pathways that lead to the activation of SAA2. | ||||||